The proliferation of antigen-primed CD8+ T cells could be stimulated by the interaction between the tumor necrosis factor ligand and cognate TNFRSF, which is beneficial for protective immunity and cancer immunotherapy (50). This evidence concerns the gene CD8A and cancer.